Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Oct;62(10):4320–4324. doi: 10.1128/iai.62.10.4320-4324.1994

Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence.

D R Wagner 1, D Heinrich 1
PMCID: PMC303111  PMID: 7927690

Abstract

In gram-negative sepsis, the activation of polymorphonuclear leukocytes (PMN) by lipopolysaccharide (LPS) and the resulting production of superoxide and other oxygen radicals may be an important cause of tissue damage. A suppression of the PMN response to LPS stimulation would be therapeutically beneficial. The aim of this study was to determine whether different polyclonal immunoglobulins (Igs; 5S-Ig, 7S-Ig, and 19S-Ig) influence the PMN response to LPS of Salmonella enteritidis in vitro. The respiratory burst activity of PMN was measured with luminol-enhanced chemiluminescence. After addition of a 5S-Ig solution containing F(ab')2 fragments of IgG and a 19S-Ig solution containing 12% polyclonal IgM, luminol-enhanced chemiluminescence was reduced by 27% (P < 0.05) and 46% (P < 0.005), respectively. However, after addition of a 7S-Ig solution containing polyclonal IgG, luminol-enhanced chemiluminescence was increased fourfold (P < 0.05). The results suggest that the influence of polyclonal Igs on PMN response to LPS stimulation is dependent on the Ig class, F(ab')2 fragments of IgG and IgM leading to LPS neutralization and IgG leading to the production of potentially toxic oxygen radicals.

Full text

PDF
4320

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen R. C., Loose L. D. Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun. 1976 Mar 8;69(1):245–252. doi: 10.1016/s0006-291x(76)80299-9. [DOI] [PubMed] [Google Scholar]
  2. Allen R. C., Stjernholm R. L., Steele R. H. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun. 1972 May 26;47(4):679–684. doi: 10.1016/0006-291x(72)90545-1. [DOI] [PubMed] [Google Scholar]
  3. Babior B. M., Kipnes R. S., Curnutte J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 1973 Mar;52(3):741–744. doi: 10.1172/JCI107236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bautista A. P., Spitzer J. J. Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin. Am J Physiol. 1990 Dec;259(6 Pt 1):G907–G912. doi: 10.1152/ajpgi.1990.259.6.G907. [DOI] [PubMed] [Google Scholar]
  5. Beutler B., Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem. 1988;57:505–518. doi: 10.1146/annurev.bi.57.070188.002445. [DOI] [PubMed] [Google Scholar]
  6. Beutler B., Milsark I. W., Cerami A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985 Aug 30;229(4716):869–871. doi: 10.1126/science.3895437. [DOI] [PubMed] [Google Scholar]
  7. Broner C. W., Shenep J. L., Stidham G. L., Stokes D. C., Hildner W. K. Effect of scavengers of oxygen-derived free radicals on mortality in endotoxin-challenged mice. Crit Care Med. 1988 Sep;16(9):848–851. doi: 10.1097/00003246-198809000-00006. [DOI] [PubMed] [Google Scholar]
  8. Bryan C. S., Reynolds K. L., Brenner E. R. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis. 1983 Jul-Aug;5(4):629–638. doi: 10.1093/clinids/5.4.629. [DOI] [PubMed] [Google Scholar]
  9. Buckley R. H., Schiff R. I. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med. 1991 Jul 11;325(2):110–117. doi: 10.1056/NEJM199107113250207. [DOI] [PubMed] [Google Scholar]
  10. Bøyum A. Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media. Methods Enzymol. 1984;108:88–102. doi: 10.1016/s0076-6879(84)08076-9. [DOI] [PubMed] [Google Scholar]
  11. Calandra T., Glauser M. P., Schellekens J., Verhoef J. Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. J Infect Dis. 1988 Aug;158(2):312–319. doi: 10.1093/infdis/158.2.312. [DOI] [PubMed] [Google Scholar]
  12. Cavaillon J. M., Fitting C., Haeffner-Cavaillon N., Kirsch S. J., Warren H. S. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun. 1990 Jul;58(7):2375–2382. doi: 10.1128/iai.58.7.2375-2382.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cooper N. R., Morrison D. C. Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J Immunol. 1978 Jun;120(6):1862–1868. [PubMed] [Google Scholar]
  14. DeChatelet L. R., Shirley P. S. Evaluation of chronic granulomatous disease by a chemiluminescence assay of microliter quantities of whole blood. Clin Chem. 1981 Oct;27(10):1739–1741. [PubMed] [Google Scholar]
  15. Flegel W. A., Wölpl A., Männel D. N., Northoff H. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun. 1989 Jul;57(7):2237–2245. doi: 10.1128/iai.57.7.2237-2245.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fleit H. B., Wright S. D., Unkeless J. C. Human neutrophil Fc gamma receptor distribution and structure. Proc Natl Acad Sci U S A. 1982 May;79(10):3275–3279. doi: 10.1073/pnas.79.10.3275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Glinz W., Grob P. J., Nydegger U. E., Ricklin T., Stamm F., Stoffel D., Lasance A. Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study. Intensive Care Med. 1985;11(6):288–294. doi: 10.1007/BF00273538. [DOI] [PubMed] [Google Scholar]
  18. Guthrie L. A., McPhail L. C., Henson P. M., Johnston R. B., Jr Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med. 1984 Dec 1;160(6):1656–1671. doi: 10.1084/jem.160.6.1656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Johansson A., Dahlgren C. Characterization of the luminol-amplified light-generating reaction induced in human monocytes. J Leukoc Biol. 1989 May;45(5):444–451. doi: 10.1002/jlb.45.5.444. [DOI] [PubMed] [Google Scholar]
  20. Kahl R., Weimann A., Weinke S., Hildebrandt A. G. Detection of oxygen activation and determination of the activity of antioxidants towards reactive oxygen species by use of the chemiluminigenic probes luminol and lucigenin. Arch Toxicol. 1987;60(1-3):158–162. doi: 10.1007/BF00296971. [DOI] [PubMed] [Google Scholar]
  21. Mayer A. M., Spitzer J. A. Continuous infusion of Escherichia coli endotoxin in vivo primes in vitro superoxide anion release in rat polymorphonuclear leukocytes and Kupffer cells in a time-dependent manner. Infect Immun. 1991 Dec;59(12):4590–4598. doi: 10.1128/iai.59.12.4590-4598.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Morrison D. C., Ryan J. L. Endotoxins and disease mechanisms. Annu Rev Med. 1987;38:417–432. doi: 10.1146/annurev.me.38.020187.002221. [DOI] [PubMed] [Google Scholar]
  23. Morrison D. C., Ulevitch R. J. The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol. 1978 Nov;93(2):526–618. [PMC free article] [PubMed] [Google Scholar]
  24. Müller-Peddinghaus R. In vitro determination of phagocyte activity by luminol- and lucigenin-amplified chemiluminescence. Int J Immunopharmacol. 1984;6(5):455–466. doi: 10.1016/0192-0561(84)90084-5. [DOI] [PubMed] [Google Scholar]
  25. Naids F. L., Rest R. F. Stimulation of human neutrophil oxidative metabolism by nonopsonized Neisseria gonorrhoeae. Infect Immun. 1991 Dec;59(12):4383–4390. doi: 10.1128/iai.59.12.4383-4390.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Raetz C. R. Biochemistry of endotoxins. Annu Rev Biochem. 1990;59:129–170. doi: 10.1146/annurev.bi.59.070190.001021. [DOI] [PubMed] [Google Scholar]
  27. Root R. K., Metcalf J., Oshino N., Chance B. H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J Clin Invest. 1975 May;55(5):945–955. doi: 10.1172/JCI108024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schmid-Schönbein G. W., Engler R. L. Granulocytes as active participants in acute myocardial ischemia and infarction. Am J Cardiovasc Pathol. 1987 Jan;1(1):15–30. [PubMed] [Google Scholar]
  29. Shimozato T., Iwata M., Tamura N. Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use. Infect Immun. 1990 May;58(5):1384–1390. doi: 10.1128/iai.58.5.1384-1390.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shiratori Y., Kawase T., Shiina S., Okano K., Sugimoto T., Teraoka H., Matano S., Matsumoto K., Kamii K. Modulation of hepatotoxicity by macrophages in the liver. Hepatology. 1988 Jul-Aug;8(4):815–821. doi: 10.1002/hep.1840080420. [DOI] [PubMed] [Google Scholar]
  31. Tate R. M., Repine J. E. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 1983 Sep;128(3):552–559. doi: 10.1164/arrd.1983.128.3.552. [DOI] [PubMed] [Google Scholar]
  32. Todeschini G., Vinante F., Benini F., Perini A., Pasini F., Cetto G. Gram-negative septicemia in patients with hematologic malignancies. Eur J Cancer Clin Oncol. 1984 Mar;20(3):327–331. doi: 10.1016/0277-5379(84)90077-4. [DOI] [PubMed] [Google Scholar]
  33. Tracey K. J., Lowry S. F., Cerami A. Cachetin/TNF-alpha in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Dec;138(6):1377–1379. doi: 10.1164/ajrccm/138.6.1377. [DOI] [PubMed] [Google Scholar]
  34. Unkeless J. C. Function and heterogeneity of human Fc receptors for immunoglobulin G. J Clin Invest. 1989 Feb;83(2):355–361. doi: 10.1172/JCI113891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Vosbeck K., Tobias P., Mueller H., Allen R. A., Arfors K. E., Ulevitch R. J., Sklar L. A. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J Leukoc Biol. 1990 Feb;47(2):97–104. doi: 10.1002/jlb.47.2.97. [DOI] [PubMed] [Google Scholar]
  36. Warren H. S., Riveau G. R., de Deckker F. A., Chedid L. A. Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor. Infect Immun. 1988 Jan;56(1):204–212. doi: 10.1128/iai.56.1.204-212.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Weber G., Heck D., Bartlett R. R., Nixdorff K. Modulation of effects of lipopolysaccharide on macrophages by a major outer membrane protein of Proteus mirabilis as measured in a chemiluminescence assay. Infect Immun. 1992 Mar;60(3):1069–1075. doi: 10.1128/iai.60.3.1069-1075.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Weingarten R., Sklar L. A., Mathison J. C., Omidi S., Ainsworth T., Simon S., Ulevitch R. J., Tobias P. S. Interactions of lipopolysaccharide with neutrophils in blood via CD14. J Leukoc Biol. 1993 May;53(5):518–524. doi: 10.1002/jlb.53.5.518. [DOI] [PubMed] [Google Scholar]
  39. Wilson M. E., Jones D. P., Munkenbeck P., Morrison D. C. Serum-dependent and -independent effects of bacterial lipopolysaccharides on human neutrophil oxidative capacity in vitro. J Reticuloendothel Soc. 1982 Jan;31(1):43–57. [PubMed] [Google Scholar]
  40. Ziegler E. J., Fisher C. J., Jr, Sprung C. L., Straube R. C., Sadoff J. C., Foulke G. E., Wortel C. H., Fink M. P., Dellinger R. P., Teng N. N. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med. 1991 Feb 14;324(7):429–436. doi: 10.1056/NEJM199102143240701. [DOI] [PubMed] [Google Scholar]
  41. Ziegler E. J., McCutchan J. A., Fierer J., Glauser M. P., Sadoff J. C., Douglas H., Braude A. I. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med. 1982 Nov 11;307(20):1225–1230. doi: 10.1056/NEJM198211113072001. [DOI] [PubMed] [Google Scholar]
  42. de Jongh-Leuvenink J., Schellekens J., Verhoef J. Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides. Infect Immun. 1990 Feb;58(2):421–426. doi: 10.1128/iai.58.2.421-426.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES